Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease
Clinical Therapeutics, ISSN: 0149-2918, Vol: 29, Issue: 12, Page: 2706-2709
2007
- 18Citations
- 25Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations18
- Citation Indexes18
- 18
- CrossRef16
- Captures25
- Readers25
- 25
Article Description
Background : Recent evidence suggests that duloxetine may increase the effect of warfarin, thereby increasing the possibility of bleeding. However, a MEDLINE search for articles published between 1980 and May 2007 (terms: duloxetine, anticoagulants, acenocoumarol, and interaction ; no language restriction) did not yield any reports of an interaction between concomitant use of duloxetine and acenocoumarol.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0149291807004146; http://dx.doi.org/10.1016/j.clinthera.2007.12.026; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=38049059297&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/18201587; https://linkinghub.elsevier.com/retrieve/pii/S0149291807004146
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know